|

GT101 Clinical Trials

2 actively recruiting trials

Pipeline

Early 1: 1Phase 1: 1

Top Sponsors

  • Grit Biotechnology2

Indications

  • Cancer2
  • Solid Tumors, Adult1
  • Adult1

Other2 trials

GT101 Injection for the Treatment of Metastatic or Recurrent Solid Tumors
Phase 1
GT101 Injection in the Treatment of Metastatic/Recurrent Advanced Solid Tumors
Early 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.